Last updated on February 2018

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

Brief description of study

The purpose of this study is to determine whether pharmacogenomic study predict antidepressant responsiveness in advance before the appearance of the drug effects until 4~6 weeks after drug administration.

Detailed Study Description

The purpose of this study is

  1. to determine whether genomic effects on antidepressant response differed by class of drug,
  2. whether genomic differences between drug responders and nonresponders predict the response of antidepressant and
  3. to construct the prediction model for antidepressant treatment in order to aid to select the their genetically matching drugs.

Clinical Study Identifier: NCT00817375

Contact Investigators or Research Sites near you

Start Over

Samsung Medical Center Kim, MD.pHD

Samsung Medical Center
Kangnam, Korea, Republic of
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.